After failing to gain sufficient market following for a family of specialized healthcare ETFs, HealthShares has decided to liquidate its 4 remaining exchange traded funds by year end.
ETFs affected include:
HealthShares™ Cancer Exchange-Traded Fund (HHK)
HealthShares™ European Drugs Exchange-Traded Fund (HRJ)
HealthShares™ Diagnostics Exchange-Traded Fund (HHD)
HealthShares™ Drug Discovery Tools Exchange-Traded Fund (HHV)
The last day of trading will be December 23, 2008.